|
Volumn 24, Issue 21, 2006, Pages 3508-
|
Troponin I and cardiovascular risk stratification in patients with testicular cancer [1]
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTHRACYCLINE;
BLEOMYCIN;
CISPLATIN;
PLATINUM DERIVATIVE;
TROPONIN I;
VON WILLEBRAND FACTOR;
ANTINEOPLASTIC AGENT;
BIOLOGICAL MARKER;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CARDIOTOXICITY;
CARDIOVASCULAR RISK;
HEART INFARCTION;
HUMAN;
LETTER;
LUNG EMBOLISM;
PRIORITY JOURNAL;
PROGNOSIS;
TESTIS CANCER;
BLOOD;
CARDIOVASCULAR DISEASE;
CHEMICALLY INDUCED DISORDER;
MALE;
NOTE;
PREDICTION AND FORECASTING;
RISK ASSESSMENT;
RISK FACTOR;
TESTIS TUMOR;
ANTHRACYCLINES;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOLOGICAL MARKERS;
CARDIOVASCULAR DISEASES;
HUMANS;
MALE;
MYOCARDIAL INFARCTION;
PREDICTIVE VALUE OF TESTS;
RISK ASSESSMENT;
RISK FACTORS;
TESTICULAR NEOPLASMS;
TROPONIN I;
|
EID: 33746849860
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2006.06.7876 Document Type: Letter |
Times cited : (12)
|
References (9)
|